drugset / Trial / NCT06681116

Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation

NCT06681116

Completed 325 enrolled ALI KAMAL M. SAMI
RandomizedParallel-groupQuadruple-blindPrevention

Summary

We assessed the effect of structured nano-water in the prevention of recurrent stone formation in patients with recurrent calcium oxalate stones and hypercalciuria.

Timeline

Start
2015-02-16
Primary completion
2020-08-24
Completion
2020-08-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 50 mg